Madersbacher S - Search Results

1

[Pathophysiology and therapy of benign prostatic hyperplasia].

Sampson N, Madersbacher S, Berger P. Sampson N, et al. Among authors: madersbacher s. Wien Klin Wochenschr. 2008;120(13-14):390-401. doi: 10.1007/s00508-008-0986-5. Wien Klin Wochenschr. 2008. PMID: 18726663 Review. German.

2

Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis.

Madersbacher S, Schatzl G, Bieglmayer C, Reiter WJ, Gassner C, Berger P, Zidek T, Marberger M. Madersbacher S, et al. Urology. 2002 Nov;60(5):869-74. doi: 10.1016/s0090-4295(02)01893-9. Urology. 2002. PMID: 12429318

3

Serum androgen levels in men: impact of health status and age.

Schatzl G, Madersbacher S, Temml C, Krenn-Schinkel K, Nader A, Sregi G, Lapin A, Hermann M, Berger P, Marberger M. Schatzl G, et al. Among authors: madersbacher s. Urology. 2003 Mar;61(3):629-33. doi: 10.1016/s0090-4295(02)02252-5. Urology. 2003. PMID: 12639660

4

EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).

Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. Madersbacher S, et al. Eur Urol. 2004 Nov;46(5):547-54. doi: 10.1016/j.eururo.2004.07.016. Eur Urol. 2004. PMID: 15474261

5

Benign prostatic hyperplasia: age-related tissue-remodeling.

Untergasser G, Madersbacher S, Berger P. Untergasser G, et al. Among authors: madersbacher s. Exp Gerontol. 2005 Mar;40(3):121-8. doi: 10.1016/j.exger.2004.12.008. Epub 2005 Jan 22. Exp Gerontol. 2005. PMID: 15763388 Review.

6

The long-term outcome of medical therapy for BPH.

Madersbacher S, Marszalek M, Lackner J, Berger P, Schatzl G. Madersbacher S, et al. Eur Urol. 2007 Jun;51(6):1522-33. doi: 10.1016/j.eururo.2007.03.034. Epub 2007 Mar 28. Eur Urol. 2007. PMID: 17416456 Review.

7

Medical treatment of lower urinary tract symptoms/benign prostatic hyperplasia: anything new in 2015.

Schauer I, Madersbacher S. Schauer I, et al. Among authors: madersbacher s. Curr Opin Urol. 2015 Jan;25(1):6-11. doi: 10.1097/MOU.0000000000000120. Curr Opin Urol. 2015. PMID: 25393269 Review.

8

Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review.

Madersbacher S, Sampson N, Culig Z. Madersbacher S, et al. Gerontology. 2019;65(5):458-464. doi: 10.1159/000496289. Epub 2019 Apr 3. Gerontology. 2019. PMID: 30943489 Free article. Review.

9

Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases.

Brössner C, Petritsch K, Fink K, Auprich M, Madersbacher S, Adlercreutz H, Rehak P, Petritsch P. Brössner C, et al. Among authors: madersbacher s. Urology. 2004 Oct;64(4):707-11. doi: 10.1016/j.urology.2004.04.046. Urology. 2004. PMID: 15491706

10

Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: therapeutic options for the man at risk.

Emberton M, Zinner N, Michel MC, Gittelman M, Chung MK, Madersbacher S. Emberton M, et al. Among authors: madersbacher s. BJU Int. 2007 Aug;100(2):249-53. doi: 10.1111/j.1464-410X.2007.07056.x. BJU Int. 2007. PMID: 17617135 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

323 results

Search Page